eFFECTOR Therapeutics (EFTR) Competitors $0.0002 0.00 (0.00%) As of 02/21/2025 09:40 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends EFTR vs. CALA, AMPE, CLVR, PXMD, ATNFW, LBPSW, AARD, AEHAW, AIMDW, and ALVOWShould you be buying eFFECTOR Therapeutics stock or one of its competitors? The main competitors of eFFECTOR Therapeutics include Calithera Biosciences (CALA), Ampio Pharmaceuticals (AMPE), Clever Leaves (CLVR), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), and Alvotech (ALVOW). These companies are all part of the "pharmaceutical products" industry. eFFECTOR Therapeutics vs. Calithera Biosciences Ampio Pharmaceuticals Clever Leaves PaxMedica 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Ainos Alvotech eFFECTOR Therapeutics (NASDAQ:EFTR) and Calithera Biosciences (NASDAQ:CALA) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, community ranking, institutional ownership, earnings, profitability and risk. Do institutionals & insiders believe in EFTR or CALA? 57.7% of eFFECTOR Therapeutics shares are held by institutional investors. 4.7% of eFFECTOR Therapeutics shares are held by insiders. Comparatively, 6.6% of Calithera Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community believe in EFTR or CALA? Calithera Biosciences received 318 more outperform votes than eFFECTOR Therapeutics when rated by MarketBeat users. However, 79.31% of users gave eFFECTOR Therapeutics an outperform vote while only 56.09% of users gave Calithera Biosciences an outperform vote. CompanyUnderperformOutperformeFFECTOR TherapeuticsOutperform Votes2379.31% Underperform Votes620.69% Calithera BiosciencesOutperform Votes34156.09% Underperform Votes26743.91% Do analysts prefer EFTR or CALA? eFFECTOR Therapeutics presently has a consensus price target of $24.00, indicating a potential upside of 11,999,900.00%. Given eFFECTOR Therapeutics' stronger consensus rating and higher probable upside, equities research analysts clearly believe eFFECTOR Therapeutics is more favorable than Calithera Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score eFFECTOR Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Calithera Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer EFTR or CALA? In the previous week, Calithera Biosciences had 1 more articles in the media than eFFECTOR Therapeutics. MarketBeat recorded 1 mentions for Calithera Biosciences and 0 mentions for eFFECTOR Therapeutics. eFFECTOR Therapeutics' average media sentiment score of 0.00 equaled Calithera Biosciences'average media sentiment score. Company Overall Sentiment eFFECTOR Therapeutics Neutral Calithera Biosciences Neutral Which has more volatility and risk, EFTR or CALA? eFFECTOR Therapeutics has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Calithera Biosciences has a beta of -0.48, meaning that its share price is 148% less volatile than the S&P 500. Is EFTR or CALA more profitable? Company Net Margins Return on Equity Return on Assets eFFECTOR TherapeuticsN/A N/A N/A Calithera Biosciences N/A N/A N/A Which has preferable earnings and valuation, EFTR or CALA? eFFECTOR Therapeutics has higher revenue and earnings than Calithera Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioeFFECTOR Therapeutics$3.55M0.00-$35.81M-$13.080.00Calithera BiosciencesN/AN/A-$39.65MN/AN/A SummaryeFFECTOR Therapeutics beats Calithera Biosciences on 8 of the 11 factors compared between the two stocks. Get eFFECTOR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EFTR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart EFTR vs. The Competition Export to ExcelMetriceFFECTOR TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$7.06B$5.84B$9.14BDividend YieldN/A2.75%4.75%3.85%P/E Ratio0.005.7326.0419.11Price / Sales0.00306.03447.4676.36Price / CashN/A65.6738.0134.83Price / Book0.006.717.644.62Net Income-$35.81M$138.33M$3.18B$245.85M7 Day PerformanceN/A-2.63%-2.00%-2.61%1 Month PerformanceN/A-2.33%-0.44%-2.14%1 Year PerformanceN/A-5.33%16.44%12.98% eFFECTOR Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EFTReFFECTOR TherapeuticsN/A$0.00flat$24.00+11,999,900.0%-100.0%$0.00$3.55M0.0010CALACalithera BiosciencesN/A$0.00flatN/A-97.0%$3,000.00N/A0.0060Analyst ForecastNews CoverageAMPEAmpio PharmaceuticalsN/A$0.00-79.0%N/A-99.9%$2,000.00N/A0.0020Analyst ForecastNews CoverageGap DownHigh Trading VolumeCLVRClever LeavesN/A$0.00-50.0%N/A-100.0%$2,000.00$17.42M0.00560Gap DownHigh Trading VolumePXMDPaxMedicaN/A$0.00-99.7%N/A-100.0%$1,000.00N/A0.002Gap DownATNFW180 Life SciencesN/A$0.01+6.5%N/A+51.5%$0.00N/A0.007News CoverageGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$13.30-7.1%N/AN/A$0.00N/A0.0018Insider TradeNews CoveragePositive NewsGap UpHigh Trading VolumeAEHAWAesther Healthcare AcquisitionN/A$0.03-7.4%N/A-13.4%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.13-0.7%N/A+138.5%$0.00$40,633.000.0040Gap UpALVOWAlvotechN/A$2.45+6.5%N/A-46.2%$0.00$391.87M0.004Gap Up Related Companies and Tools Related Companies Calithera Biosciences Alternatives Ampio Pharmaceuticals Alternatives Clever Leaves Alternatives PaxMedica Alternatives 180 Life Sciences Alternatives 4D pharma Alternatives Aardvark Therapeutics Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:EFTR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eFFECTOR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EFTR Stock Alerts